Is pre-therapeutical FDG-PET/CT capable to detect high risk tumor subvolumes responsible for local failure in non-small cell lung cancer?
- 1 June 2009
- journal article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 91 (3) , 399-404
Abstract
No abstract availableKeywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt (03ZIK042)
This publication has 31 references indexed in Scilit:
- Attenuation correction of four dimensional (4D) PET using phase-correlated 4D-computed tomographyPhysics in Medicine & Biology, 2008
- Intensity-modulated radiation therapy (IMRT) for inoperable non-small cell lung cancer: The Memorial Sloan-Kettering Cancer Center (MSKCC) experienceRadiotherapy and Oncology, 2008
- 18F-Fluorodeoxyglucose Positron Emission Tomography-Based Assessment of Local Failure Patterns in Non–Small-Cell Lung Cancer Treated With Definitive RadiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- PET-CT–Based Auto-Contouring in Non–Small-Cell Lung Cancer Correlates With Pathology and Reduces Interobserver Variability in the Delineation of the Primary Tumor and Involved Nodal VolumesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- High-Dose Radiotherapy for the Treatment of Inoperable Non–Small Cell Lung CancerThe Cancer Journal, 2007
- Risk-adaptive optimization: Selective boosting of high-risk tumor subvolumesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Phase II Multicenter Study of Induction Chemotherapy Followed by Concurrent Efaproxiral (RSR13) and Thoracic Radiotherapy for Patients With Locally Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2005
- [18F]Fluorodeoxyglucose Uptake by Positron Emission Tomography Predicts Outcome of Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2005
- Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendationsEuropean Journal of Cancer, 1999